Colorectal cancer guidelines seldom include the patient perspective.

Clinical Practice Guideines Colorectal neoplasms Guidelines as topic Patient participation Patient perspective Patient preference

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
12 2019
Historique:
received: 26 02 2019
revised: 09 08 2019
accepted: 20 08 2019
pubmed: 31 8 2019
medline: 22 5 2020
entrez: 31 8 2019
Statut: ppublish

Résumé

This study aimed to describe how colorectal practice guidelines (PGs) incorporate the patient perspective. We searched in the Guidelines International Network library, MEDLINE, National Guideline Clearinghouse, NHS Evidence database, and TRIP database. Two authors independently selected the PGs. We considered recommendations rated or worded as weak or conditional or suggesting multiple options, as potentially preference sensitive. Two authors independently evaluated if, in potentially sensitive recommendations, the patient perspective was incorporated. We included 28 PGs that contained 588 recommendations, being 256 potentially preference sensitive. Ten PGs (36%) included patients in the development process, and 12 (43%) provided information about patients' perspectives. Nine PGs (32%) included recommendations in which the patient perspective was explicitly considered, and 13 (46.4%) that recommended a discussion with the patient. From a total of 588 recommendations, 9.7% (25/256) of potentially preference-sensitive recommendations considered the patient perspective. The inclusion of patients in the development process was associated with a more frequent incorporation of the patient perspective in potentially preference sensitive recommendations (70% vs. 0%; P < 0.001). Guideline users should be aware that the incorporation of the patient perspective in colorectal cancer PGs is suboptimal. Guideline developers should make efforts to incorporate the patient perspective, especially in preference-sensitive recommendations.

Identifiants

pubmed: 31470075
pii: S0895-4356(19)30179-9
doi: 10.1016/j.jclinepi.2019.08.008
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-97

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

A Selva (A)

Department of Clinical Epidemiology and Cancer Screening, Corporació Sanitària Parc Taulí, Parc del Taulí,1, 08208 Sabadell, Spain; Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antoni Maria Claret, 167, Pavelló 18, planta 0, 08025 Barcelona, Spain; Research Network on Health Services in Chronic Diseases (REDISSEC), Spain. Electronic address: aselva@tauli.cat.

A J Sanabria (AJ)

Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antoni Maria Claret, 167, Pavelló 18, planta 0, 08025 Barcelona, Spain.

E Niño de Guzman (E)

Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antoni Maria Claret, 167, Pavelló 18, planta 0, 08025 Barcelona, Spain.

M Ballesteros (M)

Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antoni Maria Claret, 167, Pavelló 18, planta 0, 08025 Barcelona, Spain.

C Selva (C)

Department of Psychology and Educational Science, Open University of Catalonia (UOC), Rambla del Poblenou, 156, Barcelona 08018, Spain.

C Valli (C)

Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antoni Maria Claret, 167, Pavelló 18, planta 0, 08025 Barcelona, Spain.

Y Zhang (Y)

Department of Health Research Methods, Evidence, and Impact, McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada.

J J Yepes-Nuñez (JJ)

Department of Health Research Methods, Evidence, and Impact, McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada; Faculty of Medicine, Universidad de los Andes, Bogotá, Colombia.

I Solà (I)

Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antoni Maria Claret, 167, Pavelló 18, planta 0, 08025 Barcelona, Spain; CIBER Epidemiología y Salud Pública, (CIBERESP), Spain.

H Schünemann (H)

Department of Health Research Methods, Evidence, and Impact, McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada.

P Alonso-Coello (P)

Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antoni Maria Claret, 167, Pavelló 18, planta 0, 08025 Barcelona, Spain; Department of Health Research Methods, Evidence, and Impact, McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada; CIBER Epidemiología y Salud Pública, (CIBERESP), Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH